✦ LIBER ✦

Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis – authors’ reply

✍ Scribed by L. Lindström; A. Bergquist

Book ID: 108606639
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 51 KB
Volume: 35
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2012.05032.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary: ursodeoxycholic acid as chem

Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis

✍ C. Santander; R. Moreno-Otero 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Impact of inflammatory bowel disease and

Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis

✍ Phunchai Charatcharoenwitthaya; Paul Angulo; Felicity B. Enders; Keith D. Lindor 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 2 views

A longitudinal, cohort study was performed to characterize the clinical features of patients with small-duct primary sclerosing cholangitis (PSC) occurring with and without inflammatory bowel disease (IBD) and to determine the influence of IBD and the effect of ursodeoxycholic acid (UDCA) therapy on

Ursodeoxycholic acid as a chemopreventiv

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

✍ Darrell S. Pardi; Edward V. Loftus Jr; Walter K. Kremers; Jill Keach; Keith D. L 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Sa1105 Ursodiol As a Chemoprotective Age

Sa1105 Ursodiol As a Chemoprotective Agent for Colorectal Cancer in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Meta-Analysis

✍ Ashraf, Imran; Nguyen, Douglas L.; Choudhary, Abhishek; Matteson-Kome, Michelle 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 251 KB